迈克生物发布上半年业绩，归母净利润3404.25万元，下降83.12%

Core Insights - The company reported a revenue of 1.075 billion yuan for the first half of 2025, representing a year-on-year decrease of 15.94% [1] - The net profit attributable to shareholders was 34.0425 million yuan, down 83.12% year-on-year [1] - The net profit excluding non-recurring gains and losses was 63.0562 million yuan, a decrease of 68.24% year-on-year [1] - Basic earnings per share were 0.0556 yuan [1] Revenue Breakdown - Revenue from self-developed products was 872 million yuan, a decline of 6.49% year-on-year [1] - Sales volume of self-developed reagent products increased by 3.79% year-on-year [1] - Revenue from agency products was 193 million yuan, down 42.16% year-on-year [1] - Self-developed product sales accounted for 81.11% of total revenue, an increase of 8.2% [1]